Roche in ‘continued dialogue’ with FDA over Alzheimer’s prospect; culls early-stage assets in Q2 clearout
Roche in ‘continued dialogue’ with FDA over Alzheimer’s prospect; culls [...]
Roche in ‘continued dialogue’ with FDA over Alzheimer’s prospect; culls [...]
New gene therapy approach shows signs of preventing vision loss [...]
AbbVie, Roche top data transparency list, but more could be [...]
Hemab raises $55M to target multiple rare bleeding indications ntaylor [...]
Rivus’ fat-trimming therapy nabs $35M to harness our own biology [...]
In an unusual crossover, Gilead hires Arcus CMO Grossman, putting [...]
Panakès moves into biotech investing with new €150M fund ntaylor [...]
Surprise genetic discovery in macular degeneration points to new treatment [...]
Rome, backed by Arch and GV, hires science leaders to [...]
Adagio seeks IPO to bring COVID-19 antibody to market in [...]